Skip to main content
Equibles

Dr. Liam Ratcliffe

Board Member

OnKure Therapeutics, Inc. (OKUR)

Equibles does not estimate personal net worth.

Get an email with a short summary when OnKure Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get OKUR alerts

About Dr. Liam Ratcliffe

Dr. Liam Ratcliffe is recorded as Board Member at OnKure Therapeutics, Inc. (OKUR) since March 30, 2026. OnKure Therapeutics, Inc. reported in an 8-K filed March 30, 2026 that Dr. Liam Ratcliffe was appointed Class I director, effective March 27, 2026. OnKure Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at OnKure Therapeutics, Inc. includes Nicholas A. Saccomano (CEO and Board Member), Nicholas A. Saccomano, Ph.D. (CEO), Nicholas Saccomano (CEO and Board Member) and 7 others.

“On March 27, 2026, in connection with the Private Placement, the Board elected Dr. Liam Ratcliffe as a Class I director of the Company, effective and contingent on the closing of the Private Placement.”
OnKure Therapeutics, Inc. Form 8-K, filed March 30, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at OnKure Therapeutics, Inc.

Recent activity